Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Audrito

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Ebiomedicine|November 7, 2020
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancerValentina Audrito
Purinergic Signalling|March 31, 2021
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophilsValentina Audrito
The International Journal of Biochemistry & Cell Biology|February 27, 2022
NAMPT: A critical driver and therapeutic target for cancerMassimiliano Gasparrini, Valentina Audrito
Frontiers in Molecular Biosciences|January 26, 2026
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cellsJoanna Kopecka, Valentina Audrito
Frontiers in Pharmacology|March 26, 2025
Editorial: Metabolic reprogramming in cancerValentina Audrito, Elisa Giovannetti
International Journal of Molecular Sciences|October 16, 2025
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets"Laura Conti, Valentina Audrito
Frontiers in Oncology|April 9, 2020
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in InflammationValentina Audrito, Vincenzo Gianluca Messana, Silvia Deaglio
Seminars in Cell & Developmental Biology|May 7, 2019
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)Valentina Audrito, Antonella Managò, Federica Gaudino, et al.
Frontiers in Immunology|August 23, 2021
The Extracellular NADome Modulates Immune ResponsesValentina Audrito, Vincenzo Gianluca Messana, Lorenzo Brandimarte, et al.
International Journal of Molecular Sciences|September 9, 2022
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic TargetsAlice Indini, Irene Fiorilla, Luca Ponzone, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Ebiomedicine|November 7, 2020
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancerValentina Audrito
Purinergic Signalling|March 31, 2021
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophilsValentina Audrito
The International Journal of Biochemistry & Cell Biology|February 27, 2022
NAMPT: A critical driver and therapeutic target for cancerMassimiliano Gasparrini, Valentina Audrito
Frontiers in Molecular Biosciences|January 26, 2026
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cellsJoanna Kopecka, Valentina Audrito
Frontiers in Pharmacology|March 26, 2025
Editorial: Metabolic reprogramming in cancerValentina Audrito, Elisa Giovannetti
International Journal of Molecular Sciences|October 16, 2025
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets"Laura Conti, Valentina Audrito
Frontiers in Oncology|April 9, 2020
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in InflammationValentina Audrito, Vincenzo Gianluca Messana, Silvia Deaglio
Seminars in Cell & Developmental Biology|May 7, 2019
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)Valentina Audrito, Antonella Managò, Federica Gaudino, et al.
Frontiers in Immunology|August 23, 2021
The Extracellular NADome Modulates Immune ResponsesValentina Audrito, Vincenzo Gianluca Messana, Lorenzo Brandimarte, et al.
International Journal of Molecular Sciences|September 9, 2022
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic TargetsAlice Indini, Irene Fiorilla, Luca Ponzone, et al.
Pageof 5